Midfoot Osteotomy Versus 8-Plate Epiphysiodesis for Residual Metatarsal Adductus

ConditionClub Foot
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-10
SponsorAssiut University

About this trial

Epiphysiodesis

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients are eligible for participation in the study if

Age between 5 to 10 years old

Relapsed idiopathic clubfoot (CTEV)

Presence of residual metatarsal adductus

Disqualifiers

Patients are excluded for participation in the study if

Teratologic clubfoot (e.g., myelomeningocele).

Children under 4 years of mild severity that could be corrected with conservative treatment, or above 10 years old.

flexible (correctable) deformity of the foot.

Trial design

Design model

Sequential

Treatments tested in this trial

  • Midfoot Osteotomy

    Procedure/Surgery

    Group 1 Immobilization in along leg (above knee cast) for 6 weeks Non-weight bearing during casting period Cast removal followed by gradual return to weight bearing

  • 8-Plate Epiphysiodesis

    Procedure/Surgery

    NO immobilization, only protective splinting for 2 weeks as postoperative rest, after splint removal return to normal activity. Plate will be removed after full clinical and radiological correction. Further procedures e.g. tibalis anterior tendon transfer can be done as needed.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Midfoot OsteotomyActive comparator 1 intervention
Group B: 8-Plate EpiphysiodesisActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

To compare the results of the two technical procedures of surgical treatment by Radiological correction

radiological correction assessed using the Demiglio score to evaluate the outcome of the two surgical techniques.

Time frame
6 months after surgery

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: